SecSonar.com

China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

China SXT Pharmaceuticals, Inc. (SXTC) is a Drug Manufacturers - Specialty & Generic company based in CN with a market capitalization of $1.3M. Revenue declined 9.7% year-over-year and free cash flow was negative at -$2.3M. This page tracks SXTC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 75 employees · IPO Jan 4, 2019

Valuation

Valuation & price

$1.58 · as of May 17, 2026 · -99.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.08

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$296$148$1.30Jul 25Dec 25Jul 26Jul 7, 25$253.50Jul 9, 25$265.50Jul 11, 25$262.50Jul 15, 25$250.20Jul 17, 25$253.50Jul 21, 25$243.66Jul 23, 25$253.50Jul 25, 25$238.50Jul 29, 25$231.00Jul 31, 25$234.00Aug 4, 25$237.00Aug 6, 25$225.00Aug 11, 25$237.75Aug 13, 25$241.50Aug 15, 25$240.00Aug 19, 25$234.00Aug 21, 25$235.50Aug 25, 25$222.00Aug 27, 25$222.00Aug 29, 25$219.00Sep 3, 25$220.50Sep 5, 25$241.50Sep 9, 25$221.25Sep 11, 25$258.00Sep 16, 25$280.50Sep 18, 25$285.00Sep 22, 25$295.50Sep 24, 25$235.50Sep 26, 25$244.50Sep 30, 25$235.50Oct 2, 25$247.50Oct 6, 25$246.00Oct 8, 25$234.00Oct 10, 25$221.70Oct 14, 25$217.50Oct 16, 25$213.00Oct 21, 25$213.00Oct 23, 25$201.00Oct 27, 25$189.00Oct 29, 25$205.50Oct 31, 25$213.00Nov 4, 25$213.00Nov 6, 25$214.50Nov 10, 25$213.00Nov 12, 25$198.00Nov 14, 25$198.00Nov 18, 25$240.00Nov 20, 25$201.75Nov 25, 25$211.50Nov 28, 25$216.00Dec 2, 25$207.00Dec 4, 25$214.50Dec 8, 25$207.00Dec 10, 25$210.00Dec 12, 25$211.50Dec 16, 25$246.00Dec 18, 25$231.00Dec 22, 25$232.50Dec 24, 25$229.66Dec 29, 25$220.50Jan 2, 26$261.10Jan 6, 26$253.50Jan 8, 26$187.50Jan 12, 26$21.34Jan 14, 26$14.44Jan 16, 26$14.25Jan 21, 26$13.71Jan 23, 26$12.84Jan 27, 26$15.28Jan 29, 26$7.50Feb 2, 26$6.46Feb 4, 26$3.94Feb 9, 26$2.77Feb 11, 26$2.49Feb 13, 26$2.61Feb 18, 26$2.45Feb 20, 26$2.38Feb 24, 26$2.26Feb 26, 26$2.42Mar 2, 26$2.24Mar 4, 26$2.00Mar 6, 26$2.04Mar 10, 26$2.08Mar 12, 26$2.13Mar 17, 26$1.80Mar 19, 26$1.49Mar 23, 26$1.47Mar 25, 26$1.36Mar 27, 26$1.30Mar 31, 26$1.68Apr 2, 26$1.89Apr 7, 26$2.07Apr 9, 26$2.07Apr 13, 26$2.32Apr 15, 26$1.86Apr 17, 26$2.01Apr 22, 26$2.06Apr 24, 26$2.10Apr 28, 26$2.09Apr 30, 26$2.06May 4, 26$2.07May 6, 26$1.76May 8, 26$1.73May 12, 26$1.60May 14, 26$1.60May 18, 26$1.57May 20, 26$1.60May 22, 26$1.66May 28, 26$1.56Jun 1, 26$1.68Jun 3, 26$1.73Jun 5, 26$1.44Jun 9, 26$1.56Jun 11, 26$2.26Jun 15, 26$2.35Jun 17, 26$2.22Jun 22, 26$2.39Jun 24, 26$2.54Jun 26, 26$2.42Jul 2, 26$2.45
$1.3052-week range$300.00
Loading valuation history…

Fundamentals

Key fundamentals

$1.3M

Market cap

-9.7%

Revenue growth (YoY)

21.1%

Gross margin

-$2.3M

Free cash flow (USD)

-$17.1M

Net debt

Net cash position

-53.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$3.7MFY 2017$4.9MFY 2018$7.0MFY 2019$7.0MFY 2020$5.2MFY 2021$4.8MFY 2022$2.6MFY 2023$2.0MFY 2024$1.9MFY 2025$1.7M
$3.7M$1.7M

Free cash flow by year

2016 → 2025

FY 2016$85.5KFY 2017$106.7KFY 2018$869.4KFY 2019$-370.9KFY 2020$527.6KFY 2021$-1.4MFY 2022$205.8KFY 2023$-151.4KFY 2024$-1.9MFY 2025$-2.3M
$85.5K-$2.3M

Gross margin by year

2021 → 2025

FY 202159.4%FY 202248.1%FY 202321.6%FY 202428.7%FY 202521.1%
59.4%21.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 20-F filed Jul 1, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual report20-F FiledJul 1, 2026Filing
  • 6-K filingSales AgreementJun 1, 2026Filing
  • 6-K filingSecurities Purchase AgreementMay 4, 2026Filing
  • 6-K filingSecurities Purchase AgreementApr 9, 2026Filing

Questions

Frequently asked questions

What is China SXT Pharmaceuticals, Inc.'s market cap?

China SXT Pharmaceuticals, Inc. (SXTC) has a market capitalization of $1.3M.

What is SXTC's P/E ratio?

A meaningful P/E ratio is not available for SXTC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SXTC's price-to-book (P/B) ratio?

SXTC trades at 0.08 times book value per share.

Are insiders buying SXTC stock?

SEC Form 4 filings show no open-market insider buys at China SXT Pharmaceuticals, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

SBFM

Sunshine Biopharma, Inc.

$1.4M

IMCC

IM Cannabis Corp.

$1M

UPC

Universe Pharmaceuticals Inc.

$1.8M

AKAN

Akanda Corp.

$706.9K

SNOA

Sonoma Pharmaceuticals, Inc.

$2M

PRPH

ProPhase Labs, Inc.

$457.1K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.